O Renascimento da Medicina Psicodélica

Introduction: Studies about alternative medicine have multiplied in several countries such as the United States, Norway and England in recent years. Among them, I highlight psychedelic medicine that through randomized clinical trials, has already shown that psilocybin - substance present in the Psilocybe cubensis mushroom, popularly known as "magic mushrooms" - was able to induce remission of depression and anxiety symptoms, in addition to other beneficial effects that culminated in an increase of the life quality with low rate of negative effects, demonstrating a great therapeutic potential in the management of mental disorders refractory to conventional treatments. Objective of the article: This article aims to promote the discussion about psychedelic medicine, analyzing the personal experience and the interest of the population about it, which unfortunately still lacks of national studies. Methodology: Consists of an observational study in which data were obtained through the application of an online questionnaire on the Google forms platform. 12 variables were analyzed and included epidemiological data, whether the individual had any psychedelic experiences and what were the observed effects and how relevant you consider the subject.

Conclusion: The total sample was 203 participants, 74 of whom had already consumed psilocybin and the majority considered it a positive experience, as 89.2% (N=66) of them stated that they would use it again. The only factor that influenced the classification of the experience was having prior knowledge about researches in this area and most participants (67.5%) considered the topic as super relevant.